Hatteras Venture Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 12

- Investments
- 144
- Portfolio
- 46
- Exits
- 59

Hatteras Venture Partners General Information
Description
Founded in 2000, Hatteras Venture Partners is a venture capital firm based in Durham, North Carolina. The firm seeks to invest in the commercial services, healthcare devices and supplies, healthcare technology systems, pharmaceuticals and biotechnology, software, SaaS, life sciences, and oncology sectors operating in the United States.
Contact Information
- 280 South Mangum Street
- Suite 350
- Durham, NC 27701
- United States
Hatteras Venture Partners Investments (144)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Wildflower Health | 08-Mar-2022 | Later Stage VC | 0000 | Other Healthcare Technology Systems | Generating Revenue | 0000 00000000 |
0000.00 | 10-Feb-2022 | 00000 00000 | 00.00 | Other Healthcare Technology Systems | Generating Revenue | 0000 00000000 |
0000 000000000000 | 02-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
00000000 | 16-Nov-2021 | 00000 00000 | 000.00 | Drug Discovery | Startup | |
00000000000 | 08-Nov-2021 | 00000 00000 | 00.00 | Biotechnology | Generating Revenue | 0000 00000 |
0000000 0000 | 19-Oct-2021 | 00000 00000 | 0000 | Decision/Risk Analysis | Generating Revenue | |
000000 000000 0000 | 23-Sep-2021 | 00000 00000 | 00000 | Medical Records Systems | Generating Revenue | |
00000 00000 | 13-Aug-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000 00000 |
RapidPulse (Therapeutic Devices) | 23-Jun-2021 | Early Stage VC | 0000 | Therapeutic Devices | Startup | |
Veralox Therapeutics | 10-Jun-2021 | Early Stage VC | 000.00 | Drug Discovery | Startup | 00000000 0000000 00.0 |
Hatteras Venture Partners Exits (59)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
AN2 Therapeutics | 25-Mar-2022 | IPO | 0000 |
000000 00000000000 | 10-Jan-2022 | 000 00 00000000 | |
0000 0000000000 | 07-Jan-2022 | 000000000000000000 | |
00000 00000 | 07-Jan-2022 | 000 | 0000 |
000 (0000000000000 | 04-Jan-2022 | 000000000000000000 | |
000000000 | 15-Oct-2021 | 000000000000000000 | 00000 |
0000000 0000000 | 13-Sep-2021 | 000 | 00000 |
0000 | 30-Jun-2021 | 000 | 00000 |
Clinipace | 28-Apr-2021 | Merger/Acquisition | 00000 |
Vindara | 10-Mar-2021 | Merger/Acquisition | 000.00 |
Hatteras Venture Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Hatteras Venture Partners‘s full profile, request access.
Request a free trialHatteras Venture Partners Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialHatteras Venture Partners Team (24)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Clay Thorp | Co-Founder & General Partner | 00 | 0 | 0 | Durham, NC |
Christy Shaffer Ph.D | General Partner | 00 | 0 | 0 | Durham, NC |
Douglas Reed MD | General Partner | 00 | 0 | 0 | Durham, NC |
Kenneth Lee Jr. | General Partner | 0 | 0 | 0 | Durham, NC |
Robert Ingram | General Partner | 0 | 0 | 0 | Durham, NC |
Hatteras Venture Partners Co-Investors (214)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Alexandria Venture Investments | 7 | 0 |
![]() |
![]() |
|
VentureSouth | 0 | 0 |
![]() |
![]() |
|
Excelerate Health Ventures | 0 | 0 | 0 |
![]() |
![]() |
New Enterprise Associates | 0 | 0 |
![]() |
![]() |
|
Johnson & Johnson Innovation - JJDC | 0 | 0 |
![]() |
![]() |